Outset Medical, Inc.
OM · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $29 | $31 | $30 | $29 |
| % Growth | -6.3% | 5.6% | 1% | – |
| Cost of Goods Sold | $18 | $20 | $19 | $19 |
| Gross Profit | $12 | $12 | $11 | $11 |
| % Margin | 39.4% | 37.8% | 37.2% | 36.5% |
| R&D Expenses | $5 | $5 | $6 | $8 |
| G&A Expenses | $8 | $9 | $8 | $9 |
| SG&A Expenses | $22 | $23 | $22 | $25 |
| Sales & Mktg Exp. | $14 | $14 | $14 | $15 |
| Other Operating Expenses | -$0 | $0 | $0 | $0 |
| Operating Expenses | $27 | $29 | $27 | $33 |
| Operating Income | -$15 | -$17 | -$16 | -$22 |
| % Margin | -52.6% | -53.7% | -55.1% | -74.2% |
| Other Income/Exp. Net | -$2 | -$2 | -$9 | -$4 |
| Pre-Tax Income | -$17 | -$18 | -$26 | -$26 |
| Tax Expense | $0 | $0 | $0 | -$0 |
| Net Income | -$18 | -$19 | -$26 | -$26 |
| % Margin | -60.6% | -59% | -86.7% | -87% |
| EPS | -1 | -1.04 | -7.44 | -0.5 |
| % Growth | 3.8% | 86% | -1,388% | – |
| EPS Diluted | -1 | -1.04 | -7.44 | -0.5 |
| Weighted Avg Shares Out | 18 | 18 | 3 | 3 |
| Weighted Avg Shares Out Dil | 18 | 18 | 3 | 3 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $2 | $2 | $2 |
| Interest Expense | $3 | $3 | $4 | $6 |
| Depreciation & Amortization | $0 | $1 | $1 | $1 |
| EBITDA | -$14 | -$17 | -$21 | -$18 |
| % Margin | -46.3% | -53.7% | -70% | -62.5% |